[ Price : $8.95]
FDA tells Neuromed that it cannot approve its pending NDA for Exalgo (hydromorphone HCl) extended release tablets, indicated for m...[ Price : $8.95]
As FDA circles to defend its controversial dental amalgam rule and its shadowy principal author, a dental toxicology group urges t...[ Price : $8.95]
FDA orders a new warning on certain local anesthetics about the potential for chondrolysis (necrosis and destruction of cartilage)...[ Price : $8.95]
DDMAC says that a Shire Fosrenol brochure omits all risk information, overstates the drugs efficacy, and broadens its indication.[ Price : $8.95]
FDA says that Genzyme must resolve deficiencies at its Allston Landing manufacturing facility before it can receive approval to ma...[ Price : $8.95]
CDRH alerts healthcare practitioners to reports of death and serious complications associated with use of negative pressure wound ...[ Price : $8.95]
Cardiovascular Systems (CSI) recalls all lots of the ViperSheath Sheath Introducer after receiving reports about sheath stretching...[ Price : $8.95]
DDMAC says that a patient profile card for Eisais Dacogen overstates the drugs efficacy and omits important risk information and m...